Register Here

2019 Executive Sponsors

BD Medical
Credence medsystems
Phillips-Medisize

2019 Associate Sponsors

Halozyme
Pfizer
PharmaCircle

2019 Technology Sponsors

Altaviz
Battelle
BDD Pharma
Bespak
Biocorp
Cambridge Design Partnership
Common Sensing
Datwyler
Enable Injections
Evonik
Gerresheimer Medical Systems
Harro Höfliger Verpackungsmaschinen GmbH
InnoCore Pharmaceuticals
leon nanodrugs
Nemera
Oakwood Labs
Portal Instruments
Quantex Vernay
Sensile Medical
SMC Ltd
Sonceboz
Stevanato Group

2019 Exhibitors

Baumann Group
CBSET
Drug Delivery Experts
Haselmeier
Intertech
Manta
Owen Mumford
Polysciences
Product Creation Studio
Renishaw
SHL Group
Team Consulting
Ximedica

2019 Media Partners

Big4Bio
Drug Development & Delivery
PharmaVOICE

2018 Executive Sponsors

3M
BD Medical
Medimmune
Phillips-Medisize

2018 Associate Sponsors

Battelle
Catalent
Flex
Halozyme
Pfizer
Pharmacircle

2018 Technology Sponsors

4P Therapeutics
Adare Pharmaceuticals
Adocia
Altaviz
Aquestive
BDD Pharma
Bespak
Biocorp
Cambridge Design Partnership
Common Sensing
Congruence
Credence medsystems
Cureport
Daré  Bioscience
Datwyler
DelSiTech
Enable Injections
Evonik
Exicure
Gerresheimer Medical Systems
Harro Höfliger Verpackungsmaschinen GmbH
Ichor Medical
Ileo Science
InnoCore Pharmaceuticals
InnoMedica
Interface Biologics
Intract Pharma
leon nanodrugs
Lyndra
Matinas Biopharma
Nanexa
Ocular Therapeutix
Pharmaero
Portal Instruments
Qpharma
Quantex Vernay
Recro Gainsville
Sensile Medical
Serina Therapeutics
SMC Ltd
Sorrel Medical
Ypsomed

2018 Exhibitors

Baumann Group
CBSET
Drug Delivery Experts
DS Technology
Haselmeier
Intertech
Manta
NN Life Sciences
Oakwood Labs
Phosphorex
Polysciences
Renishaw
Sonceboz
Stevanato Group
Team Consulting
teamtechnik
Ursatec
West Pharmaceutical Services
Ximedica

2018 Supporting Sponsor

TTP plc

2018 Soapbox Sponsors

Better Sense
Cam Med
Cinti Medical, Inc
Consegna Pharma
Massachusetts General Hospital (MGH)
SiNon Therapeutics
Wyss Institute

2018 Media Partners

Big3Bio
Drug Development & Delivery
Mass Bio
Med Device Online
OndrugDelivery
Pharma Tech Outlook
Pharmaceutical Online
PharmaCircle
Pharmalicensing
pharmaphorum
SciDoc Publishers
Technology Networks

2018 Conference Supporter

MCD Group

Overview

The drug delivery industry is expected to experience robust growth over the next five to ten years, primarily due to the increasing prevalence of chronic conditions and the growing geriatric population. Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.

The 8th annual Partnership Opportunities in Drug Delivery (PODD) business development event covered the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. The PODD event featured a wide range of innovative drug delivery technologies that could potentially improve the delivery of various types of drugs, including proteins, peptides, mRNA therapies, oncology therapeutics, and small molecules.

Podcast: An Insight into PODD PODD Celebration

The 8th annual event was chaired by:


Barbara Lueckel, PhD
Global Business Development Director, Roche Partnering InnovationRoche


2018 Featured Keynotes included:

Robert Langer

Robert Langer, PhD
David H. Koch Institute Professor,
MIT

Amy Schulman

Amy Schulman, JD
Co-founder and CEO, Lyndra and Partner, Polaris

Jeffrey Karp, PhD
Professor of Medicine, Harvard Medical School

Justin Wright 2018

Justin Wright, PhD
Global Head of Innovation, Novartis


2018 Track Chairs:

Nima Akhavein, PhD
Associate Fellow and Scientific Leader, GSK

Ulrich Brüggemann
Head Academics and Innovation, Global Medical Devices DevelopmentSanofi US

Mathias Romacker
Senior Director, Device Strategy, Pfizer

Michael Cucolo

Michael Cucolo
Director of Business Development, BMS

Manuel Sanchez-Felix, PhD
Senior FellowNovel Delivery Technologies /Chemical and Pharmaceutical ProfilingNovartis Institute for BioMedical Research

Ann Daugherty

Ann L Daugherty, PhD
Senior Manager, Drug DeliveryGenentech


In addition to presenting cutting-edge technologies and drug delivery solutions, the PODD event also presented expert panel discussions related to the latest challenges and trends in drug delivery today:

  • Protein and peptide drug delivery, including non-invasive administration
  • High-volume, subcutaneous delivery to optimize delivery and lower healthcare costs
  • Gene therapy: the potential of mRNA therapies and vaccines
  • Digital health technologies to improve patient adherence and outcomes
  • Ophthalmic delivery targeting difficult back of the eye diseases
  • Management of the combination product lifecycle: post-market surveillance
  • Disruptive new models for advancing development and commercialization of early stage technologies
  • Strategic considerations for evaluating and utilizing external delivery technologies
  • Patient input on the design and development of next-generation drug delivery systems

PODD attracts more than 350 delegates from drug delivery, pharmaceutical, biotechnology, and medical device companies globally.

Key benefits in 2018 included:

  • Hearing from renowned biomedical engineer and entrepreneur, Dr Robert Langer, and highly accomplished investor and biotech executive, Amy Schulman, as they addressed collaboration in drug delivery and what it takes to bring game-changing technologies and therapeutics to the market.
  • Learning about the latest drug delivery technology solutions for both small and large molecule drugs, ranging from oral, transdermal, and transmucosal dosage forms to more patient-friendly delivery devices (more than 45 presentations and 50 exhibitors).
  • Networking with key decision makers from pharmaceutical, biotechnology, and medical device companies and exploring areas for potential collaboration (more than 8 hours of networking).
  • Discovering the current drug delivery needs of pharma and biotech companies and determining what they are looking for in terms of external delivery technologies.
  • Understanding the potential impact digital health applications and digitally-enabled drug delivery systems can have on improving patient adherence and overall health outcomes.

The PODD promise:

  1. To present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
  2. To provide drug delivery and specialty pharmas with a platform to present their technologies.
  3. To offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.

Sincerely,

 

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith-2018

Meredith Sands
Executive Director, Business Development

Michelle McDermott
Conference Producer

Meg

Meg Gould
Senior Conference Planner

Geeta Bachani
Business Development Manager

Bre Bugbee
Marketing Manager


Testimonials

  • "Incredible! Fantastic overview of the industry, recent, partnerships and opportunities for the future. Helpful input on panels, speaker presentations and what's in the pipeline. Great networking opportunities and sharing insights with colleagues. Hard to choose just one area - was all invaluable."

    - Kristin King, Rogers Sciences

  • "Overall very satisfied. Best was networking, coming across new technologies that I did not necessarily have on the radar, and the speaker’s program."

    - Gregoire Schwach, Roche

  • "Was a great conference and getting better every year!"

    - Rudy Emmelot, IntraTab Labs

  • "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

    - Sina Eetezadi, Roche Pharmaceuticals

  • "Congratulations on a very successful conference! It is a very unique conference and I enjoyed it very much."

    - Avinash G. Thombre, PhD, Pfizer Inc

  • "I was honestly very much impressed by the conference, the set up with presentations and panels and the high level number of executives from the different stakeholders."

    - Sven Stegemann, PhD, Geriatric Medicine Society

  • "This was a great partnering event for us. In addition to our product development services, we have a couple of proprietary technologies that we are promoting. The right group of Directors, Exec Dir, VPs were at the meeting who were all looking for delivery technologies."

    - Chris Rhodes, Drug Delivery Experts